Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (551-560 of 933) with videos related to

Pageof 94
Sort By:
Life (Basel, Switzerland)|July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder CancerDanijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Concordance Rate of Colposcopy in Detecting Cervical Intraepithelial LesionsFrederik A Stuebs, Anna K Dietl, Annika Behrens, et al.
Histopathology|November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologistsKeith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
Virchows Archiv : an International Journal of Pathology|August 28, 2024
ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entityAbbas Agaimy, Josephine K Dermawan, Florian Haller, et al.
The Journal of Pathology|February 6, 2019
Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapyTimon Heide, Angela Maurer, Monika Eipel, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
International Journal of Cancer|September 30, 2010
The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinomaBastian Keck, Robert Stoehr, Sven Wach, et al.
Plos One|October 30, 2013
Collecting duct carcinomas represent a unique tumor entity based on genetic alterationsFrank Becker, Kerstin Junker, Martin Parr, et al.
European Urology|December 7, 2007
ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancerFlorian R Fritzsche, Monika Jung, Angelika Tölle, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder CancerJohannes Breyer, Sanzhar Shalekenov, Atiqullah Aziz, et al.
Pageof 94

Showing results (551-560 of 933) with videos related to

Sort By:
Pageof 94
Life (Basel, Switzerland)|July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder CancerDanijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Concordance Rate of Colposcopy in Detecting Cervical Intraepithelial LesionsFrederik A Stuebs, Anna K Dietl, Annika Behrens, et al.
Histopathology|November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologistsKeith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
Virchows Archiv : an International Journal of Pathology|August 28, 2024
ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entityAbbas Agaimy, Josephine K Dermawan, Florian Haller, et al.
The Journal of Pathology|February 6, 2019
Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapyTimon Heide, Angela Maurer, Monika Eipel, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
International Journal of Cancer|September 30, 2010
The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinomaBastian Keck, Robert Stoehr, Sven Wach, et al.
Plos One|October 30, 2013
Collecting duct carcinomas represent a unique tumor entity based on genetic alterationsFrank Becker, Kerstin Junker, Martin Parr, et al.
European Urology|December 7, 2007
ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancerFlorian R Fritzsche, Monika Jung, Angelika Tölle, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder CancerJohannes Breyer, Sanzhar Shalekenov, Atiqullah Aziz, et al.
Pageof 94